These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6259041)

  • 21. Hypothyroidism-induced changes in triiodothyronine binding to nuclei and cytosol-binding proteins in rat liver.
    Murthy PV; Banovac K; McKenzie JM
    Endocrinology; 1978 Apr; 102(4):1129-36. PubMed ID: 217615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humoral modulation of hepatic nuclear triiodothyronine receptors in the cross-circulated rat.
    Short J; McDermott P; Truitte D
    Horm Metab Res; 1982 Apr; 14(4):224. PubMed ID: 6282730
    [No Abstract]   [Full Text] [Related]  

  • 23. Evidence for an active step in thyroid hormone transport to nuclei: drug inhibition of L-125I-triiodothyronine binding to nuclear receptors in rat pituitary tumor cells.
    Halpern J; Hinkle PM
    Endocrinology; 1982 Mar; 110(3):1070-2. PubMed ID: 6276153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium ipodate increases triiodothyronine action in vivo.
    Hays JH; Eil C; Smallridge RC
    J Endocrinol Invest; 1992; 15(7):507-12. PubMed ID: 1332995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triiodothyronine nuclear receptor and the role of non-histone protein factors in in vitro triiodothyronine binding.
    Bismuth J; Anselmet A; Torresani J
    Biochim Biophys Acta; 1985 Jun; 840(2):271-9. PubMed ID: 2986714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Furosemide, fenclofenac, diclofenac, mefenamic acid and meclofenamic acid inhibit specific T3 binding in isolated rat hepatic nuclei.
    Topliss DJ; Hamblin PS; Kolliniatis E; Lim CF; Stockigt JR
    J Endocrinol Invest; 1988 May; 11(5):355-60. PubMed ID: 3183298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear receptors for L-triiodothyronine in quail liver.
    Weirich RT; McNabb FM
    Gen Comp Endocrinol; 1984 Jan; 53(1):90-9. PubMed ID: 6325294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of divalent cations on the binding of 3,5,3'-triiodothyronine to isolated rat liver nuclei.
    Rodriguez-Peña A; Bernal J
    Endocrinology; 1982 Jan; 110(1):246-53. PubMed ID: 6274620
    [No Abstract]   [Full Text] [Related]  

  • 29. Cholecystographic agents and sulfobromophthalein inhibit the binding of L-thyroxine to plasma membranes of rat hepatocytes.
    Felicetta JV; Czanko R; Huber-Smith MJ; McCann DS
    Endocrinology; 1986 Jun; 118(6):2500-4. PubMed ID: 3698921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triiodothyronine nuclear receptor in chick embryo: nature and properties of hepatic receptor.
    Bellabarba D; Lehoux JG
    Endocrinology; 1981 Oct; 109(4):1017-25. PubMed ID: 6269827
    [No Abstract]   [Full Text] [Related]  

  • 31. Triiodothyronine receptors during maturation.
    DeGroot LJ; Robertson M; Rue PA
    Endocrinology; 1977 Jun; 100(6):1511-5. PubMed ID: 192539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of fatty acids on rat liver nuclear T3-receptor binding.
    Mazzachi BC; Kennedy JA; Wellby ML; Edwards AM
    Metabolism; 1992 Jul; 41(7):788-92. PubMed ID: 1619999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new unextracted-sample radioimmunoassay method for hepatic endogenous nuclear L-tri-iodothyronine content. Validity of its use in determining nuclear receptor binding characteristics.
    Yagura T; Walfish PG
    Biochem J; 1982 Dec; 208(3):641-9. PubMed ID: 6299277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Triiodothyronine binding by the liver nuclei and mitochondria].
    Rachev RR; Dimitrov MI; Filipova EKh; Dimitrov OA; Gaĭdarova KD
    Probl Endokrinol (Mosk); 1979; 25(6):60-5. PubMed ID: 230474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfhydryl groups regulate thyroid hormone binding at nuclear receptor sites: further evidence for a separate binding site for reverse T3.
    Smith HC; Eastman CJ
    Biochem Biophys Res Commun; 1980 Oct; 96(3):1178-83. PubMed ID: 6254523
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduction in hepatic triiodothyronine binding capacity induced by fasting.
    Burman KD; Lukes Y; Wright FD; Wartofsky L
    Endocrinology; 1977 Oct; 101(4):1331-4. PubMed ID: 198201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Triiodothyronine binding and norepinephrine uptake in the heart and liver].
    Utevskiĭ AM; Tapbergenov SO
    Ukr Biokhim Zh (1978); 1982; 54(3):307-10. PubMed ID: 6285571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identical pattern of release of specific triiodothyronine receptors by micrococcal nuclease from rat cerebral cortex and liver nuclei.
    Silva JE
    Endocrinology; 1983 Aug; 113(2):699-705. PubMed ID: 6307648
    [No Abstract]   [Full Text] [Related]  

  • 39. Glucagon administration decreases hepatic nuclear triiodothyronine binding capacity.
    Dillmann WH; Bonner RA; Oppenheimer JH
    Endocrinology; 1978 May; 102(5):1633-6. PubMed ID: 217631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of an antibody against rat liver nuclear T3 receptor.
    Faure R; Ruel J; Dussault JH
    Biochem Cell Biol; 1986 Apr; 64(4):377-80. PubMed ID: 3013247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.